Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users | MicrobiomeTrials← Back to trialsNCT06659029
Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
RecruitingOBSERVATIONAL
Trial Details
Start: 2025-07-01Est. Completion: 2031-04-15
Enrollment target: 442 participants Locations- Research Site, Wilmington, North Carolina, United States
Other microbiome trials you might be interested in
Rare DiseasesGeneralized Myasthenia Gravis (gMG)
This is a multicenter, non-interventional, retrospective-prospective, single-arm observational study designed to describ…
Kazan', RussiaEst. completion Dec 31, 2029
Systemic Lupus Erythematosus (SLE)
In this study, researchers will learn more about a study drug called litifilimab (BIIB059) in participants with systemic…
Phoenix, United StatesCompleted Mar 29, 2030
Phase 3
ENROLLING_BY_INVITATION
Lupus Erythematosus, Systemic
The goal of this clinical study is to learn about the long-term safety and tolerability of cenerimod in adult patients w…
Aurora, United StatesCompleted Sep 2032